Back to FDA Applications sponsored by PFIZER IRELAND

FDA Drug Application 020895 by PFIZER IRELAND

Application Number020895
Application Type New Drug Application
Sponsor ApplicantPFIZER IRELAND
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Priority
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP03/27/1998N527000   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20895ltr.pdf 3/27/1998
AP03/27/1998N529000   http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/viagralabel2.pdf 3/27/1998
AP03/27/1998N18298000   http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm162833.htm 10/30/2007
AP03/27/1998N22231000   http://www.accessdata.fda.gov/drugsatfda_docs/NDA/98/viagra/viagra_toc.cfm 4/13/2009
AP05/4/1998SCM19227001   http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020895_S001_VIAGRA.pdf 2/19/2008
AP08/13/1998SLR19228002   http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020895_S002_VIAGRA.pdf 2/19/2008
AP011/24/1998SLR19229003   http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020895_S003_VIAGRA.pdf 2/19/2008
AP012/22/1998SLR       
AP01/21/2000SLR       
AP06/18/1999SLR       
AP02/14/2002SCM       
AP011/16/1999SCS       
AP01/20/2000SCS       
AP03/16/2000SCM       
AP09/19/2002SLR2390011   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20895se8-018,slr011,015ltr.pdf 9/19/2002
AP09/19/2002SLR2391011   http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20895s11s15s18lbl.pdf 9/19/2002
AP01/2/2002SLR       
AP08/24/2001SCM       
AP09/19/2002SLR2493015   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20895se8-018,slr011,015ltr.pdf 9/19/2002
AP09/19/2002SLR2494015   http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20895s11s15s18lbl.pdf 9/19/2002
AP08/24/2001SCM       
AP09/19/2002SE82495018   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20895se8-018,slr011,015ltr.pdf 9/19/2002
AP09/19/2002SE82496018   http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20895s11s15s18lbl.pdf 9/19/2002
AP06/26/2006SLR14384020   http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020895s20lbl.pdf 6/28/2006
AP06/26/2006SLR14407020   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020895s020ltr.pdf 7/3/2006
AP07/8/2005SLR11966021   http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020895s021lbl.pdf 7/8/2005
AP07/8/2005SLR12000021   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/020895s021ltr.pdf 7/15/2005
AP010/6/2006SLR15074023   http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020895s023lbl.pdf 10/11/2006
AP010/6/2006SLR15092023   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020895s023ltr.pdf 10/13/2006
AP02/25/2008SLR19299026   http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020895s026lbl.pdf 2/26/2008
AP02/25/2008SLR19306026   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020895s026ltr.pdf 2/27/2008
AP010/18/2007SLR18246027   http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020895s027lbl.pdf 10/18/2007
AP010/18/2007SLR18275027   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020895s027ltr.pdf 10/22/2007
AP08/6/2008SLR20604028   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020895s028, s029ltr.pdf 8/13/2008
AP08/6/2008SLR20605029   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020895s028, s029ltr.pdf 8/13/2008
AP01/11/2010SLR24517033   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020895s033ltr.pdf 1/15/2010
AP01/11/2010SLR24552033   http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020895s033lbl.pdf 1/20/2010
AP01/31/2011SLR27676036   http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020895s036lbl.pdf 1/31/2011
AP01/31/2011SLR27709036   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020895s036ltr.pdf 2/4/2011
AP03/11/2014SLR38751039   http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/20895s039s042lbl.pdf 3/11/2014
AP03/11/2014SLR38753039   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/020895Orig1s039,s042ltr.pdf 3/11/2014
AP02/3/2015SCM       
AP03/25/2014SCM       
AP03/11/2014SE838754042   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/020895Orig1s039,s042ltr.pdf 3/11/2014
AP03/11/2014SE838752042   http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/20895s039s042lbl.pdf 3/11/2014
AP01/26/2015SCM       
AP03/26/2015SLR42308044   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020895Orig1s044ltr.pdf 3/27/2015
AP03/26/2015SLR42320044   http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020895s044lbl.pdf 3/27/2015
AP09/16/2015SLR43908045   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020895Orig1s045ltr.pdf 9/17/2015
AP09/16/2015SLR43966045   http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020895s045lbl.pdf 9/23/2015




Back to FDA Applications sponsored by PFIZER IRELAND